Concepedia

Claire Illac

CI

Statistics

Publications

4

Citations

249

H-Index

4

Active since

2017

Affiliations

Institut Claudius Regaud(Current)

Inserm

Centre de Recherches en Cancérologie de Toulouse

Université Toulouse III - Paul Sabatier

Institut universitaire du cancer de Toulouse Oncopole

Claire Illac is an author at Institut Claudius Regaud specializing in oncology, immunology, and tumor immunology.

ORCID

Publications per year

2017–2021

4

Publications

4

CD163-positive tumor-associated macrophages and CD8-positive cytotoxic lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma patients: An immunohistochemical analysis of the biopsies fromthe French OS2006 phase 3 trial

Anne Gomez‐Brouchet, Claire Illac, Julia Gilhodes et al. · OncoImmunology · 2017 · 170 citations · Full text

, , +17

Dual Relief of T-lymphocyte Proliferation and Effector Function Underlies Response to PD-1 Blockade in Epithelial Malignancies

Camille-Charlotte Balança, Clara‐Maria Scarlata, Marie Michelas et al. · Cancer Immunology Research · 2020 · 42 citations

, , +17

Prognostic value of lymphovascular space invasion in early-stage cervical cancer

Ariane Weyl, Claire Illac, Amélie Lusque et al. · International Journal of Gynecological Cancer · 2020 · 25 citations

, , +17

Effect of tumor burden and radical surgery on survival difference between upfront, early interval or delayed cytoreductive surgery in ovarian cancer

Martina Aida Ángeles, Bastien Cabarrou, Antonio Gil‐Moreno et al. · Journal of Gynecologic Oncology · 2021 · 12 citations · Full text

, , +17

1–4 of 4